Cargando…

Current Evidence Supporting the Role of Immune Response in ATTRv Amyloidosis

Hereditary transthyretin (ATTRv) amyloidosis with polyneuropathy, also known as familial amyloid polyneuropathy (FAP), represents a progressive, heterogeneous, severe, and multisystemic disease caused by pathogenic variants in the TTR gene. This autosomal-dominant neurogenetic disorder has an adult...

Descripción completa

Detalles Bibliográficos
Autores principales:	Plantone, Domenico, Primiano, Guido, Righi, Delia, Romano, Angela, Luigetti, Marco, De Stefano, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572348/ https://www.ncbi.nlm.nih.gov/pubmed/37830598 http://dx.doi.org/10.3390/cells12192383

Ejemplares similares

Serum Inflammatory Profile in Hereditary Transthyretin Amyloidosis: Mechanisms and Possible Therapeutic Implications
por: Luigetti, Marco, et al.
Publicado: (2022)

Machine Learning for Early Diagnosis of ATTRv Amyloidosis in Non-Endemic Areas: A Multicenter Study from Italy
por: Di Stefano, Vincenzo, et al.
Publicado: (2023)

Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy
por: Magliano, Lorenza, et al.
Publicado: (2021)

Trajectories of Kidney Function in Patients with ATTRv Treated with Gene Silencers
por: Luigetti, Marco, et al.
Publicado: (2022)

A Metabolic Signature of Hereditary Transthyretin Amyloidosis: A Pilot Study
por: Luigetti, Marco, et al.
Publicado: (2022)

Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects
por: Russo, Massimo, et al.
Publicado: (2020)

Ocular Morpho-Functional Evaluation in ATTRv Pre-Symptomatic Carriers: A Case Series
por: Maceroni, Martina, et al.
Publicado: (2023)

The patient journey toward a diagnosis of hereditary transthyretin (ATTRv) amyloidosis
por: Vera-Llonch, Montserrat, et al.
Publicado: (2021)

Urinary Transthyretin as a Biomarker in ATTRv Val50Met Amyloidosis
por: Matsushita, Hiroaki, et al.
Publicado: (2022)

Drug and Gene Therapy for Treating Variant Transthyretin Amyloidosis (ATTRv) Neuropathy
por: Dardiotis, Efthimios, et al.
Publicado: (2023)

Muscle MRI as a Useful Biomarker in Hereditary Transthyretin Amyloidosis: A Pilot Study
por: Primiano, Guido, et al.
Publicado: (2021)

Variant Transthyretin Amyloidosis (ATTRv) in Hungary: First Data on Epidemiology and Clinical Features
por: Pozsonyi, Zoltán, et al.
Publicado: (2021)

Ocular findings in patients with acquired ATTRv amyloidosis following domino liver transplantation
por: Kitahara, Junya, et al.
Publicado: (2023)

Nerve Conduction Studies of Dorsal Sural Nerve: Normative Data and Its Potential Application in ATTRv Pre-Symptomatic Subjects
por: Luigetti, Marco, et al.
Publicado: (2022)

Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Perspectives on Improving Patient Care
por: Luigetti, Marco, et al.
Publicado: (2020)

Vitamin D in Neurological Diseases
por: Plantone, Domenico, et al.
Publicado: (2022)

Use of Drugs for ATTRv Amyloidosis in the Real World: How Therapy Is Changing Survival in a Non-Endemic Area
por: Russo, Massimo, et al.
Publicado: (2021)

Disease risk estimates in V30M variant transthyretin amyloidosis (A-ATTRv) from Mallorca
por: Cisneros-Barroso, E., et al.
Publicado: (2023)

ATTRv in Lazio-Italy: A High-Prevalence Region in a Non-Endemic Country
por: Luigetti, Marco, et al.
Publicado: (2021)

The Clinical and Economic Burden of Newly Diagnosed Hereditary Transthyretin (ATTRv) Amyloidosis: A Retrospective Analysis of Claims Data
por: Reddy, Sheila R., et al.
Publicado: (2020)

Patisiran Enhances Muscle Mass after Nine Months of Treatment in ATTRv Amyloidosis: A Study with Bioelectrical Impedance Analysis and Handgrip Strength
por: Di Stefano, Vincenzo, et al.
Publicado: (2022)

Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen
por: Coelho, Teresa, et al.
Publicado: (2022)

A narrative review and expert recommendations on the assessment of the clinical manifestations, follow-up, and management of post-OLT patients with ATTRv amyloidosis
por: Casasnovas, Carlos, et al.
Publicado: (2023)

Prevalence estimation of ATTRv in China based on genetic databases
por: Yongsheng, Zheng, et al.
Publicado: (2023)

Kidney involvement in hereditary transthyretin amyloidosis: is there a role for cystatin C?
por: D'Ambrosio, Viola, et al.
Publicado: (2022)

Hereditary transthyretin amyloidosis overview
por: Manganelli, Fiore, et al.
Publicado: (2020)

Case Report: Hereditary transthyretin (ATTRv) amyloidosis: The p.G103R mutation of the transthyretin gene in a Han Chinese family is associated with vitreous hemorrhage
por: Shen, Junhui, et al.
Publicado: (2022)

Ocular Involvement in Hereditary Transthyretin Amyloidosis: A Case Series Describing Novel Potential Biomarkers
por: Minnella, Angelo Maria, et al.
Publicado: (2021)

Quantitative Sensory Testing in Late-Onset ATTRv Presymptomatic Subjects: A Single Center Experience
por: Tozza, Stefano, et al.
Publicado: (2022)

Deterioration after Liver Transplantation and Transthyretin Stabilizer Administration in a Patient with ATTRv Amyloidosis with a Leu58Arg (p.Leu78Arg) TTR Variant
por: Hikishima, Sadao, et al.
Publicado: (2022)

Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy
por: Gentile, Luca, et al.
Publicado: (2021)

Ocular Involvement in Hereditary Amyloidosis
por: Minnella, Angelo Maria, et al.
Publicado: (2021)

A novel TTR mutation (p.Ala65Val) underlying late-onset hereditary transthyretin (ATTRv) amyloidosis with mixed cardiac and neuropathic phenotype: a case report
por: Thimm, Andreas, et al.
Publicado: (2022)

Cutaneous amyloid is a biomarker in early ATTRv neuropathy and progresses across disease stages
por: Freeman, Roy, et al.
Publicado: (2022)

Study of the parent-of-origin effect in monogenic diseases with variable age of onset. Application on ATTRv
por: Alarcon, Flora, et al.
Publicado: (2023)

A case of severe increase of liver enzymes in a ATTRv patient after one year of inotersen treatment
por: Severi, Daniele, et al.
Publicado: (2022)

The hidden story behind gender differences in familial amyloid polyneuropathy (FAP) ATTRV30M
por: Santos, Diana, et al.
Publicado: (2015)

A compound score to screen patients with hereditary transthyretin amyloidosis
por: Tozza, Stefano, et al.
Publicado: (2022)

Pure psychiatric presentation in a patient with Fahr's disease
por: Renna, Rosaria, et al.
Publicado: (2014)

Renal Involvement in Hereditary Transthyretin Amyloidosis: An Italian Single-Centre Experience
por: Ferraro, Pietro Manuel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ii6ule27aj71jv0bbv7ku4u56v